AUSTAR Reports Stable Capital Structure in October 2026 Monthly Return

Bulletin Express11-02

Hong Kong—Austar Lifesciences Limited (AUSTAR) has filed its Monthly Return for the period ended 31 October 2026, confirming no changes to its share capital structure.

The authorised share capital remains at 10.00 billion ordinary shares with a par value of HKD 0.01 each, representing HKD 100.00 million in aggregate. Issued shares were unchanged at 512.58 million, and the company continues to hold zero treasury shares.

AUSTAR affirmed that it met the Hong Kong Stock Exchange’s minimum 25% public‐float requirement as of month-end. The filing also shows no share option exercises, warrant conversions, or other equity-linked movements during the month, and no Hong Kong Depositary Receipts are outstanding.

The return was submitted by Company Secretary Mak Yuk Kiu on 2 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment